| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |